Product
MenACWY
Aliases
MenACWY vaccine, Menveo
6 clinical trials
6 indications
Indication
MeningitisIndication
MeningococcalIndication
Salmonella infectionIndication
EbolaIndication
ShigellosisIndication
COVID-19Clinical trial
A Phase IIIB, Randomized, Controlled, Observer-blind Study to Evaluate Safety and Immunogenicity of GSK's Meningococcal ABCWY Vaccine When Administered in Healthy Adolescents and Adults, Previously Primed With Meningococcal ACWY VaccineStatus: Completed, Estimated PCD: 2023-05-03
Clinical trial
A Phase IIa Observer-blind, Randomized, Controlled, Age-de-escalation, Single Center Interventional Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GVGH iNTS Vaccine Against S. Typhimurium and S. Enteritidis, in Adults, Children and Infants, Including Dose-finding in Infants, in AfricaStatus: Recruiting, Estimated PCD: 2026-04-27
Clinical trial
A Phase 2 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV and MVA-BN®-Filo in Infants Aged 4-11 Months in Guinea and Sierra LeoneStatus: Completed, Estimated PCD: 2022-08-22
Clinical trial
Safety and Immunogenicity of a Shigella-Tetravalent Bioconjugate Vaccine: A Phase 1/2 Randomized Controlled and Age Descending Study Including Dose Finding in 9 Month Old InfantsStatus: Completed, Estimated PCD: 2022-09-01
Clinical trial
A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19Status: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult VolunteersStatus: Active (not recruiting), Estimated PCD: 2024-03-31